81 related articles for article (PubMed ID: 11992471)
1. Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors.
Tomasini MC; Ferraro L; Bebe BW; Tanganelli S; Cassano T; Cuomo V; Antonelli T
J Neurosci Res; 2002 May; 68(4):449-53. PubMed ID: 11992471
[TBL] [Abstract][Full Text] [Related]
2. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study.
Ferraro L; Tomasini MC; Gessa GL; Bebe BW; Tanganelli S; Antonelli T
Cereb Cortex; 2001 Aug; 11(8):728-33. PubMed ID: 11459762
[TBL] [Abstract][Full Text] [Related]
3. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
Pistis M; Ferraro L; Pira L; Flore G; Tanganelli S; Gessa GL; Devoto P
Brain Res; 2002 Sep; 948(1-2):155-8. PubMed ID: 12383968
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
5. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
[TBL] [Abstract][Full Text] [Related]
6. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration.
Nava F; Carta G; Battasi AM; Gessa GL
Br J Pharmacol; 2000 Jul; 130(6):1201-10. PubMed ID: 10903956
[TBL] [Abstract][Full Text] [Related]
7. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
Hayakawa K; Mishima K; Nozako M; Hazekawa M; Ogata A; Fujioka M; Harada K; Mishima S; Orito K; Egashira N; Iwasaki K; Fujiwara M
Life Sci; 2007 Mar; 80(16):1466-71. PubMed ID: 17289082
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
Nava F; Carta G; Colombo G; Gessa GL
Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
[TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.
Antonelli T; Tomasini MC; Tattoli M; Cassano T; Finetti S; Mazzoni E; Trabace L; Carratù MR; Cuomo V; Tanganelli S; Ferraro L
Neurochem Int; 2006 Nov; 49(6):568-76. PubMed ID: 16777266
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.
Antonelli T; Ferraro L; Fuxe K; Finetti S; Fournier J; Tanganelli S; De Mattei M; Tomasini MC
Cereb Cortex; 2004 Apr; 14(4):466-73. PubMed ID: 15028650
[TBL] [Abstract][Full Text] [Related]
11. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
Darmani NA
Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
[TBL] [Abstract][Full Text] [Related]
12. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
14. delta 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons.
Hernández ML; García-Gil L; Berrendero F; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1997 Apr; 8(2):83-91. PubMed ID: 9188039
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.
Järbe TU; Andrzejewski ME; DiPatrizio NV
Pharmacol Biochem Behav; 2002 Nov; 73(4):911-9. PubMed ID: 12213538
[TBL] [Abstract][Full Text] [Related]
16. CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.
Tseng AH; Craft RM
Psychopharmacology (Berl); 2004 Feb; 172(1):25-30. PubMed ID: 14991224
[TBL] [Abstract][Full Text] [Related]
17. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.
Beardsley PM; Martin BR
Eur J Pharmacol; 2000 Jan; 387(1):47-53. PubMed ID: 10633159
[TBL] [Abstract][Full Text] [Related]
18. Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor.
Downer E; Boland B; Fogarty M; Campbell V
Neuroreport; 2001 Dec; 12(18):3973-8. PubMed ID: 11742222
[TBL] [Abstract][Full Text] [Related]
19. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
20. Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation.
Wiley JL; Jefferson RG; Grier MC; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2001 Mar; 296(3):1013-22. PubMed ID: 11181936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
